Global Heart Failure Drugs Market Size, Status and Forecast 2022

November 2017 | 108 pages | ID: GA04A0E79F3EN
QYResearch

Abstracts

This report studies the global Heart Failure Drugs market, analyzes and researches the Heart Failure Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Pfizer
• Novartis
• Merck
• Sanofi
• Johnson & Johnson
• AstraZeneca
• GlaxoSmithKline
• Amgen
• Bayer
• BMS
• Cardiorentis
• Cytokinetics
• Ono Pharmaceuticals
• Mylan
• NCPC
• Xinhua Group
• Xudong Haipu Pharmaceutical

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, the product can be split into

• Injection
• Capsule
• Tablets

Market segment by Application, Heart Failure Drugs can be split into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Heart Failure Drugs Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF HEART FAILURE DRUGS

1.1 Heart Failure Drugs Market Overview
  1.1.1 Heart Failure Drugs Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Heart Failure Drugs Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Heart Failure Drugs Market by Type
  1.3.1 Injection
  1.3.2 Capsule
  1.3.3 Tablets
1.4 Heart Failure Drugs Market by End Users/Application
  1.4.1 Hospital Pharmacies
  1.4.2 Retail Pharmacies
  1.4.3 Online Pharmacies

2 GLOBAL HEART FAILURE DRUGS COMPETITION ANALYSIS BY PLAYERS

2.1 Heart Failure Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Pfizer
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Heart Failure Drugs Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 Novartis
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Heart Failure Drugs Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 Merck
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Heart Failure Drugs Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 Sanofi
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Heart Failure Drugs Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 Johnson & Johnson
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Heart Failure Drugs Revenue (Value) (2012-2017)
  3.5.5 Recent Developments
3.6 AstraZeneca
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Heart Failure Drugs Revenue (Value) (2012-2017)
  3.6.5 Recent Developments
3.7 GlaxoSmithKline
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Heart Failure Drugs Revenue (Value) (2012-2017)
  3.7.5 Recent Developments
3.8 Amgen
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Heart Failure Drugs Revenue (Value) (2012-2017)
  3.8.5 Recent Developments
3.9 Bayer
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Heart Failure Drugs Revenue (Value) (2012-2017)
  3.9.5 Recent Developments
3.10 BMS
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Heart Failure Drugs Revenue (Value) (2012-2017)
  3.10.5 Recent Developments
3.11 Cardiorentis
3.12 Cytokinetics
3.13 Ono Pharmaceuticals
3.14 Mylan
3.15 NCPC
3.16 Xinhua Group
3.17 Xudong Haipu Pharmaceutical

4 GLOBAL HEART FAILURE DRUGS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)

4.1 Global Heart Failure Drugs Market Size by Type (2012-2017)
4.2 Global Heart Failure Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Heart Failure Drugs in Future
4.4 Top Consumer/End Users of Heart Failure Drugs

5 UNITED STATES HEART FAILURE DRUGS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Heart Failure Drugs Market Size (2012-2017)
5.2 United States Heart Failure Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU HEART FAILURE DRUGS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Heart Failure Drugs Market Size (2012-2017)
6.2 EU Heart Failure Drugs Market Size and Market Share by Players (2016 and 2017)

7 JAPAN HEART FAILURE DRUGS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Heart Failure Drugs Market Size (2012-2017)
7.2 Japan Heart Failure Drugs Market Size and Market Share by Players (2016 and 2017)

8 CHINA HEART FAILURE DRUGS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Heart Failure Drugs Market Size (2012-2017)
8.2 China Heart Failure Drugs Market Size and Market Share by Players (2016 and 2017)

9 INDIA HEART FAILURE DRUGS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Heart Failure Drugs Market Size (2012-2017)
9.2 India Heart Failure Drugs Market Size and Market Share by Players (2016 and 2017)

10 SOUTHEAST ASIA HEART FAILURE DRUGS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Heart Failure Drugs Market Size (2012-2017)
10.2 Southeast Asia Heart Failure Drugs Market Size and Market Share by Players (2016 and 2017)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)

11.1 Global Heart Failure Drugs Market Size (Value) by Regions (2017-2022)
  11.1.1 United States Heart Failure Drugs Revenue and Growth Rate (2017-2022)
  11.1.2 EU Heart Failure Drugs Revenue and Growth Rate (2017-2022)
  11.1.3 Japan Heart Failure Drugs Revenue and Growth Rate (2017-2022)
  11.1.4 China Heart Failure Drugs Revenue and Growth Rate (2017-2022)
  11.1.5 India Heart Failure Drugs Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia Heart Failure Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Heart Failure Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Heart Failure Drugs Market Size by Application (2017-2022)

12 HEART FAILURE DRUGS MARKET DYNAMICS

12.1 Heart Failure Drugs Market Opportunities
12.2 Heart Failure Drugs Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Heart Failure Drugs Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Heart Failure Drugs Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Heart Failure Drugs Product Scope
Figure Global Heart Failure Drugs Market Size (Million USD) (2012-2017)
Table Global Heart Failure Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Heart Failure Drugs Market Share by Regions in 2016
Figure United States Heart Failure Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Heart Failure Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Heart Failure Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Heart Failure Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Heart Failure Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Heart Failure Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Heart Failure Drugs Market Share by Type in 2016
Figure Injection Market Size (Million USD) and Growth Rate (2012-2017)
Figure Capsule Market Size (Million USD) and Growth Rate (2012-2017)
Figure Tablets Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Heart Failure Drugs Market Share by Application in 2016
Table Key Downstream Customer in Hospital Pharmacies
Figure Heart Failure Drugs Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2012-2017)
Table Key Downstream Customer in Retail Pharmacies
Figure Heart Failure Drugs Market Size (Million USD) and Growth Rate in Retail Pharmacies (2012-2017)
Table Key Downstream Customer in Online Pharmacies
Figure Heart Failure Drugs Market Size (Million USD) and Growth Rate in Online Pharmacies (2012-2017)
Table Heart Failure Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Heart Failure Drugs Market Size Share by Players in 2016
Figure Heart Failure Drugs Market Size Share by Players in 2017
Table Pfizer Basic Information List
Table Heart Failure Drugs Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Heart Failure Drugs Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Heart Failure Drugs Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Heart Failure Drugs Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Heart Failure Drugs Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Heart Failure Drugs Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Heart Failure Drugs Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Heart Failure Drugs Business Revenue Market Share in 2016
Table Johnson & Johnson Basic Information List
Table Heart Failure Drugs Business Revenue (Million USD) of Johnson & Johnson (2012-2017)
Figure Johnson & Johnson Heart Failure Drugs Business Revenue Market Share in 2016
Table AstraZeneca Basic Information List
Table Heart Failure Drugs Business Revenue (Million USD) of AstraZeneca (2012-2017)
Figure AstraZeneca Heart Failure Drugs Business Revenue Market Share in 2016
Table GlaxoSmithKline Basic Information List
Table Heart Failure Drugs Business Revenue (Million USD) of GlaxoSmithKline (2012-2017)
Figure GlaxoSmithKline Heart Failure Drugs Business Revenue Market Share in 2016
Table Amgen Basic Information List
Table Heart Failure Drugs Business Revenue (Million USD) of Amgen (2012-2017)
Figure Amgen Heart Failure Drugs Business Revenue Market Share in 2016
Table Bayer Basic Information List
Table Heart Failure Drugs Business Revenue (Million USD) of Bayer (2012-2017)
Figure Bayer Heart Failure Drugs Business Revenue Market Share in 2016
Table BMS Basic Information List
Table Heart Failure Drugs Business Revenue (Million USD) of BMS (2012-2017)
Figure BMS Heart Failure Drugs Business Revenue Market Share in 2016
Table Cardiorentis Basic Information List
Table Heart Failure Drugs Business Revenue (Million USD) of Cardiorentis (2012-2017)
Figure Cardiorentis Heart Failure Drugs Business Revenue Market Share in 2016
Table Cytokinetics Basic Information List
Table Heart Failure Drugs Business Revenue (Million USD) of Cytokinetics (2012-2017)
Figure Cytokinetics Heart Failure Drugs Business Revenue Market Share in 2016
Table Ono Pharmaceuticals Basic Information List
Table Heart Failure Drugs Business Revenue (Million USD) of Ono Pharmaceuticals (2012-2017)
Figure Ono Pharmaceuticals Heart Failure Drugs Business Revenue Market Share in 2016
Table Mylan Basic Information List
Table Heart Failure Drugs Business Revenue (Million USD) of Mylan (2012-2017)
Figure Mylan Heart Failure Drugs Business Revenue Market Share in 2016
Table NCPC Basic Information List
Table Heart Failure Drugs Business Revenue (Million USD) of NCPC (2012-2017)
Figure NCPC Heart Failure Drugs Business Revenue Market Share in 2016
Table Xinhua Group Basic Information List
Table Heart Failure Drugs Business Revenue (Million USD) of Xinhua Group (2012-2017)
Figure Xinhua Group Heart Failure Drugs Business Revenue Market Share in 2016
Table Xudong Haipu Pharmaceutical Basic Information List
Table Heart Failure Drugs Business Revenue (Million USD) of Xudong Haipu Pharmaceutical (2012-2017)
Figure Xudong Haipu Pharmaceutical Heart Failure Drugs Business Revenue Market Share in 2016
Table Global Heart Failure Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Heart Failure Drugs Market Size Share by Type in 2012
Figure Global Heart Failure Drugs Market Size Share by Type in 2013
Figure Global Heart Failure Drugs Market Size Share by Type in 2014
Figure Global Heart Failure Drugs Market Size Share by Type in 2015
Figure Global Heart Failure Drugs Market Size Share by Type in 2016
Figure Global Heart Failure Drugs Market Size Share by Type in 2017
Table Global Heart Failure Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Heart Failure Drugs Market Size (Million USD) by Application in 2012
Figure Global Heart Failure Drugs Market Size (Million USD) by Application in 2013
Figure Global Heart Failure Drugs Market Size (Million USD) by Application in 2014
Figure Global Heart Failure Drugs Market Size (Million USD) by Application in 2015
Figure Global Heart Failure Drugs Market Size (Million USD) by Application in 2016
Figure Global Heart Failure Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Heart Failure Drugs
Figure United States Heart Failure Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Heart Failure Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Heart Failure Drugs Market Size Share by Players in 2016
Figure United States Heart Failure Drugs Market Size Share by Players in 2017
Figure EU Heart Failure Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Heart Failure Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Heart Failure Drugs Market Size Share by Players in 2016
Figure EU Heart Failure Drugs Market Size Share by Players in 2017
Figure Japan Heart Failure Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Heart Failure Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Heart Failure Drugs Market Size Share by Players in 2016
Figure Japan Heart Failure Drugs Market Size Share by Players in 2017
Figure China Heart Failure Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Heart Failure Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Heart Failure Drugs Market Size Share by Players in 2016
Figure China Heart Failure Drugs Market Size Share by Players in 2017
Figure India Heart Failure Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Heart Failure Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Heart Failure Drugs Market Size Share by Players in 2016
Figure India Heart Failure Drugs Market Size Share by Players in 2017
Figure Southeast Asia Heart Failure Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Heart Failure Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Heart Failure Drugs Market Size Share by Players in 2016
Figure Southeast Asia Heart Failure Drugs Market Size Share by Players in 2017
Figure Global Heart Failure Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Heart Failure Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Heart Failure Drugs Market Size Share by Regions in 2017
Figure Global Heart Failure Drugs Market Size Share by Regions in 2022
Figure United States Heart Failure Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Heart Failure Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Heart Failure Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Heart Failure Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Heart Failure Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Heart Failure Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Heart Failure Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Heart Failure Drugs Market Size Share by Type in 2017
Figure Global Heart Failure Drugs Market Size Share by Type in 2022
Table Global Heart Failure Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Heart Failure Drugs Market Size (Million USD) by Application in 2017
Figure Global Heart Failure Drugs Market Size (Million USD) by Application in 2022